General Information of Disease (ID: DIS2C0N3)

Disease Name Generalized epilepsy with febrile seizures plus, type 7
Synonyms
febrile seizures, familial, 3B; GEFSP7; Gefs+, type 7; SCN9A generalised epilepsy with febrile seizures plus; SCN9A generalized epilepsy with febrile seizures plus; generalized epilepsy with febrile seizures plus caused by mutation in SCN9A; generalized epilepsy with febrile seizures plus, type 7; generalised epilepsy with febrile seizures plus caused by mutation in SCN9A
Definition Any generalized epilepsy with febrile seizures plus in which the cause of the disease is a mutation in the SCN9A gene.
Disease Hierarchy
DISJE0UU: Generalized epilepsy with febrile seizures plus
DIS2C0N3: Generalized epilepsy with febrile seizures plus, type 7
Disease Identifiers
MONDO ID
MONDO_0013470
MESH ID
C567827
UMLS CUI
C2751778
OMIM ID
613863
MedGen ID
416630

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
SCN9A TT4G2JS Limited CausalMutation [1]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SCN9A DTQC85B Strong Autosomal dominant [2]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
SCN9A OTGSKLL8 Strong Autosomal dominant [2]
------------------------------------------------------------------------------------

References

1 Null mutation in SCN9A in which noxious stimuli can be detected in the absence of pain.Neurology. 2014 Oct 21;83(17):1577-80. doi: 10.1212/WNL.0000000000000913. Epub 2014 Sep 24.
2 A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet. 2009 Sep;5(9):e1000649. doi: 10.1371/journal.pgen.1000649. Epub 2009 Sep 18.